Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Hair restoration can enhance a facial plastic surgery practice with careful patient selection and detailed follow-up.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Hair growth dysfunction involves various conditions with limited treatment options.

Alopecia areata severity is influenced by hair loss, emotional, and financial burdens.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Thymoma with alopecia areata may be linked to abnormal immune cells.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

AI can improve alopecia areata diagnosis with high accuracy.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Exosome therapy successfully regrew and restored natural hair color in a man with stress-related hair loss.